Invesco Private Capital, Inc.
Follow13F filer, CIK 1128452, NEW YORK, NY
Invesco Private Capital, Inc. reported $282,837,000 across 8 holdings for the quarter ended 2018-06-30, in a 13F-HR filed 2018-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001567619-18-000823
- Period
- 2018-06-30
- Reported value
- $283M
- Holdings
- 8
- Top 10 weight
- 100%
- New
- 5
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MDBnew | +54,145 | $2.69M |
| SPOTnew | +3,409 | $574K |
| FORESCOUT TECHNOLOGIES INCnew | +6,647 | $228K |
| CLOUDERA INCnew | +15,064 | $205K |
| DIPLOMAT PHARMACY INCnew | +6,965 | $178K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| XENEreduced | -93,061 | -$856K |
| EXCO RESOURCES INCreduced | -1,303,414 | -$91.4K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2018
Share positions as resolved from 13F-HR 0001567619-18-000823, largest first. % of portfolio is the value over $282,837,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| NVGSNAVIGATOR HLDGS LTD | 21,863,874 | $277M | 97.79% | 0 | Timeline | ||
| MDBMONGODB INC | 54,145 | $2.69M | 0.95% | new | Timeline | ||
| XENEXENON PHARMACEUTICALS INC | 248,823 | $2.29M | 0.81% | -93,061 | Timeline | ||
| SPOTSPOTIFY TECHNOLOGY S A | 3,409 | $574K | 0.2% | new | Timeline | ||
| FORESCOUT TECHNOLOGIES INCFORESCOUT TECHNOLOGIES INC | 6,647 | $228K | 0.08% | new | |||
| CLOUDERA INCCLOUDERA INC | 15,064 | $205K | 0.07% | new | |||
| DIPLOMAT PHARMACY INCDIPLOMAT PHARMACY INC | 6,965 | $178K | 0.06% | new | |||
| EXCO RESOURCES INCEXCO RESOURCES INC | 1,397,621 | $98K | 0.03% | -1,303,414 |
How Q2 2018 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001567619-18-000823 | base | 2018-08-14 | acceptance time not in the bulk data set |